With the shortage, which pertains specifically to all formulations and concentrations of GE Healthcare’s Omnipaque (iohexol), expected to last until mid-June, several organizations have alluded that conservation efforts are of critical importance.

All formulations and concentrations of GE Healthcare’s Omnipaque (iohexol) are expected to be in short supply until mid-June due to COVID lockdowns where the contrast is manufactured.

Hospital and health systems saw incremental economic improvements in March, with rising margins and fewer COVID-19 cases and hospitalizations. 

Not all states are equal when it comes to the best places to work as a nurse.

The COVID-19 pandemic has left hospitals facing higher costs across the board, according to a recent report from the American Hospital Association (AHA).

Sixty-two percent of those surveyed believe significant reliance on other countries for medicines is among the biggest contributing factor to medicine shortages, according to new survey results.

“Our dedicated staff are committed to getting lifesaving treatments delivered to the patients who need them,” MURR's executive director said in a statement on Feb. 9.

However, Q4 bright spots included “robust” order intake with 4% growth, driven by gains in its Diagnosis & Treatment business, leaders said Wednesday.